The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation
Abstract
PML is a nuclear phosphoprotein that was first identified as part of a translocated chromosomal fusion product associated with acute promyelocytic leukaemia (APL). PML localises to distinct nuclear multi-protein complexes termed ND10, Kr bodies, PML nuclear bodies and PML oncogenic domains (PODs), which are disrupted in APL and are the targets for immediate early viral proteins, although little is known about their function. In a yeast two-hybrid screen, we first identified a ubiquitin-like protein named PIC1 (now known as SUMO-1), which interacts and co-localises with PML in vivo. More recent studies have now shown that SUMO-1 covalently modifies a number of target proteins including PML, RanGAP1 and IκBα and is proposed to play a role in either targeting modified proteins and/or inhibiting their degradation. The precise molecular role for the SUMO-1 modification of PML is unclear, and the specific lysine residues within PML that are targeted for modification and the PML sub-domains necessary for mediating the modification in vivo are unknown. Here we show that SUMO-1 covalently modifies PML both in vivo and in vitro and that the modification is mediated either directly or indirectly by the interaction of UBC9 with PML through the RING finger domain. Using site-specific mutagenesis, we have identified the primary PML-SUMO-1 modification site as being part of the nuclear localisation signal (Lys487 or Lys490). However SUMO-1 modification is not essential for PML nuclear localisation as only nuclear PML is modified. The sequence of the modification site fits into a consensus sequence for SUMO-1 modification and we have identified several other nuclear proteins which could also be targets for SUMO-1. We show that SUMO-1 modification appears to be dependant on the correct subcellular compartmentalisation of target proteins. We also find that the APL-associated fusion protein PML-RARA is efficiently modified in vitro, resulting in a specific and SUMO-1-dependent degradation of PML-RARA. Our results provide significant insights into the role of SUMO-1 modification of PML in both normal cells and the APL disease state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Enzymatic Amplification of DNA In Vitro: The Polymerase Chain Reaction
Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G., & Erlich, H. (1986) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1986.051.01.032 · Cited by 3,558
Mahajan, R., Delphin, C., Guan, T., Gerace, L., & Melchior, F. (1997) · Cell · doi:10.1016/s0092-8674(00)81862-0 · Cited by 1,256
Matunis, M. J., Coutavas, E., & Blobel, G. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.6.1457 · Cited by 1,197
SUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
Self-citationA novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A., & Evans, R. M. (1994) · Cell · doi:10.1016/0092-8674(94)90340-9 · Cited by 785
Conti, E., Uy, M., Leighton, L., Blobel, G., & Kuriyan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81419-1 · Cited by 783
Muller, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.61 · Cited by 674
Dalton, S., & Treisman, R. (1992) · Cell · doi:10.1016/0092-8674(92)90194-h · Cited by 672
Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., & Dejean, A. (1994) · Cell · doi:10.1016/0092-8674(94)90341-7 · Cited by 652
Does this have a familiar RING?
Saurin, A. J., Borden, K. L. B., Boddy, M. N., & Freemont, P. S. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)80017-x · Cited by 635
Self-citationJohnson, E. S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5509 · Cited by 553
Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures
Skinner, P. J., Koshy, B. T., Cummings, C. J., Klement, I. A., Helin, K., Servadio, A., Zoghbi, H. Y., & Orr, H. T. (1997) · Nature · doi:10.1038/40153 · Cited by 523
Ubc9p Is the Conjugating Enzyme for the Ubiquitin-like Protein Smt3p
Johnson, E. S., & Blobel, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26799 · Cited by 500
The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.
Koken, M. H., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., & Chomienne, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06356.x · Cited by 499
Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins
Seufert, W., Futcher, B., & Jentsch, S. (1995) · Nature · doi:10.1038/373078a0 · Cited by 495
Characterization of a Zinc Finger Gene Disrupted by the t(15;17) in Acute Promyelocytic Leukemia
Goddard, A. D., Borrow, J., Freemont, P. S., & Solomon, E. (1991) · Science · doi:10.1126/science.1720570 · Cited by 458
Self-citationZhu, J., Koken, M. H. M., Quignon, F., Chelbi-Alix, M. K., Degos, L., Wang, Z. Y., Chen, Z., & de Thé, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3978 · Cited by 427
Kastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Gaub, M. P., Durand, B., Lanotte, M., Berger, R., & Chambon, P. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05095.x · Cited by 415
Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M., & Parkinson, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6581-6591.1998 · Cited by 402
Self-citationPML induces a novel caspase-independent death process
Quignon, F., De Bels, F., Koken, M., Feunteun, J., Ameisen, J.-C., & de Thé, H. (1998) · Nature Genetics · doi:10.1038/3068 · Cited by 374
Ubch9 conjugates SUMO but not ubiquitin
Desterro, J. M. P., Thomson, J., & Hay, R. T. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01305-7 · Cited by 365
Self-citationBoddy, M. N., Howe, K. M., Etkin, L. D., Solomon, E., & Freemont, P. S. (1996) · PubMed · Cited by 348
Self-citationOkura, T., Gong, L., Kamitani, T., Wada, T., Okura, I., Wei, C. F., Chang, H. M., & Yeh, E. T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4277 · Cited by 335
Transport into and out of the cell nucleus
Gorlich, D. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2721 · Cited by 331
Sternsdorf, T., Jensen, K., & Will, H. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.7.1621 · Cited by 331
Borden, K. L., Boddy, M. N., Lally, J., O'Reilly, N. J., Martin, S., Howe, K., Solomon, E., & Freemont, P. S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07139.x · Cited by 328
Self-citationPMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR.
Perez, A., Kastner, P., Sethi, S., Lutz, Y., Reibel, C., & Chambon, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05986.x · Cited by 292
Mahajan, R., Gerace, L., & Melchior, F. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.2.259 · Cited by 289
PML, a growth suppressor disrupted in acute promyelocytic leukemia.
Mu, Z. M., Chin, K. V., Liu, J. H., Lozano, G., & Chang, K. S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6858 · Cited by 288
A novel zinc finger coiled-coil domain in a family of nuclear proteins
Reddy, B. A., Etkin, L. D., & Freemont, P. S. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90308-v · Cited by 266
Self-citationPML protein expression in hematopoietic and acute promyelocytic leukemia cells
Daniel, M., Koken, M., Romagne, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M., Degos, L., Chomienne, C., & de The, H. (1993) · Blood · doi:10.1182/blood.v82.6.1858.1858 · Cited by 251
Covalent Modification of PML by the Sentrin Family of Ubiquitin-like Proteins
Kamitani, T., Nguyen, H. P., Kito, K., Fukuda-Kamitani, T., & Yeh, E. T. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3117 · Cited by 207
Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2
Saitoh, H., Sparrow, D. B., Shiomi, T., Pu, R. T., Nishimoto, T., Mohun, T. J., & Dasso, M. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70044-2 · Cited by 193
Structure, Organization, and Dynamics of Promyelocytic Leukemia Protein Nuclear Bodies
Hodges, M., Tissot, C., Howe, K., Grimwade, D., & Freemont, P. S. (1998) · The American Journal of Human Genetics · doi:10.1086/301991 · Cited by 177
Self-citationPreferential Modification of Nuclear Proteins by a Novel Ubiquitin-like Molecule
Kamitani, T., Nguyen, H. P., & Yeh, E. T. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14001 · Cited by 175
The PML gene encodes a phosphoprotein associated with the nuclear matrix
Chang, K., Fan, Y., Andreeff, M., Liu, J., & Mu, Z. (1995) · Blood · doi:10.1182/blood.v85.12.3646.bloodjournal85123646 · Cited by 134
Borden, K. L. B., Lally, J. M., Martin, S. R., O’Reilly, N., Solomon, E., & Freemont, P. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1601 · Cited by 129
Self-citationAnalysis of the Growth and Transformation Suppressor Domains of Promyelocytic Leukemia Gene, PML
Le, X., Yang, P., & Chang, K.-S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.130 · Cited by 126
Le, X., Vallian, S., Mu, Z.-M., Hung, M., & Chang, K.-S. (1998) · Oncogene · doi:10.1038/sj.onc.1201705 · Cited by 98
PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu.
Liu, H., Mu, Z. M., & Chang, K. S. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.6.1965 · Cited by 91
Grimwade, D. J., & Solomon, E. (1997) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60479-9_6 · Cited by 50
Self-citationProtein regulation: Tag wrestling with relatives of ubiquitin
Hodges, M., Tissot, C., & Freemont, P. S. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00477-0 · Cited by 35
Self-citation
Cited by
Johnson, E. S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074118 · Cited by 1,675
Hay, R. T. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.012 · Cited by 1,622
Self-citationMdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
Bernardi, R., & Pandolfi, P. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2277 · Cited by 879
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Tatham, M. H., Geoffroy, M.-C., Shen, L., Plechanovova, A., Hattersley, N., Jaffray, E. G., Palvimo, J. J., & Hay, R. T. (2008) · Nature Cell Biology · doi:10.1038/ncb1716 · Cited by 847
Self-citation
Metadata
- Authors
- Duprez, E., Saurin, A. J., Desterro, J. M., Lallemand-Breitenbach, V., Howe, K., Boddy, M. N., Solomon, E., Thé, H. D., Hay, R. T., & Freemont, P. S.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 1999-02-01
- Volume
- 112
- Issue
- 3
- Pages
- 381-393
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2132147221
- Cited by
- 312
- References
- 42
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.